Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,008,383
  • Shares Outstanding, K 61,358
  • Annual Sales, $ 78,590 K
  • Annual Income, $ -146,960 K
  • 60-Month Beta 2.22
  • Price/Sales 36.49
  • Price/Cash Flow N/A
  • Price/Book 4.24
Trade KYMR with:

Options Overview Details

View History
  • Implied Volatility 55.23% ( -0.99%)
  • Historical Volatility 45.95%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 169.84% on 10/20/23
  • IV Low 55.23% on 09/20/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 63
  • Put/Call OI Ratio 1.47
  • Today's Open Interest 2,513
  • Open Int (30-Day) 2,121

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.83
  • Number of Estimates 13
  • High Estimate -0.67
  • Low Estimate -1.02
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +7.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.90 +11.39%
on 09/06/24
50.69 -3.53%
on 09/19/24
+2.40 (+5.16%)
since 08/20/24
3-Month
29.24 +67.24%
on 06/28/24
50.69 -3.53%
on 09/19/24
+17.63 (+56.38%)
since 06/20/24
52-Week
9.60 +409.38%
on 11/02/23
50.69 -3.53%
on 09/19/24
+31.49 (+180.87%)
since 09/20/23

Most Recent Stories

More News
Stocks Undercut by Chip Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.04%. US stocks Monday...

$SPX : 5,688.29 (-0.44%)
SPY : 567.17 (-0.67%)
$DOWI : 41,932.06 (-0.22%)
DIA : 419.50 (-0.45%)
$IUXX : 19,715.73 (-0.63%)
QQQ : 481.15 (-0.46%)
ZNZ24 : 114-215 (-0.05%)
ARM : 139.19 (-1.00%)
MRO : 27.92 (+0.11%)
AMD : 154.23 (-1.60%)
MU : 89.63 (+0.43%)
LRCX : 768.48 (-2.61%)
Stocks Turn Lower as Chip Stocks Slide

The S&P 500 Index ($SPX ) (SPY ) is down -0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.08%. US stocks today are mixed, with the...

$SPX : 5,688.29 (-0.44%)
SPY : 567.17 (-0.67%)
$DOWI : 41,932.06 (-0.22%)
DIA : 419.50 (-0.45%)
$IUXX : 19,715.73 (-0.63%)
QQQ : 481.15 (-0.46%)
ZNZ24 : 114-215 (-0.05%)
ARM : 139.19 (-1.00%)
MU : 89.63 (+0.43%)
NVDA : 116.44 (-1.21%)
MRO : 27.92 (+0.11%)
LRCX : 768.48 (-2.61%)
Stocks Mostly Higher on Hopes for Lower Interest Rates

The S&P 500 Index ($SPX ) (SPY ) is up +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.35%. US stocks today are mixed, with the...

$SPX : 5,688.29 (-0.44%)
SPY : 567.17 (-0.67%)
$DOWI : 41,932.06 (-0.22%)
DIA : 419.50 (-0.45%)
$IUXX : 19,715.73 (-0.63%)
QQQ : 481.15 (-0.46%)
ZNZ24 : 114-215 (-0.05%)
DVN : 40.38 (-1.44%)
SLB : 42.51 (-0.56%)
MRO : 27.92 (+0.11%)
COP : 110.70 (+0.14%)
OXY : 51.29 (-1.42%)
S&P Futures Tick Higher Ahead of Powell’s Testimony, U.S. Inflation Data and Earnings Awaited

September S&P 500 E-Mini futures (ESU24) are trending up +0.15% this morning as investors looked ahead to further testimony from Federal Reserve Chair Jerome Powell while also bracing for Thursday’s...

ESU24 : 5,702.50 (-0.27%)
PFG : 85.17 (-0.53%)
NVDA : 116.44 (-1.21%)
KYMR : 48.80 (-0.47%)
ALB : 86.51 (-3.16%)
JPM : 210.49 (unch)
WFC : 55.74 (-0.11%)
C : 61.87 (-1.82%)
KOG.O.DX : 1,047.000 (+0.58%)
VVPR : 1.3025 (-5.62%)
AEHR : 12.33 (-5.01%)
SGH : 19.99 (+0.96%)
Assured Guaranty, Kymera rise; BP, Helen of Troy fall, Tuesday, 7/9/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Assured Guaranty, Kymera rise; BP, Helen of Troy fall

HLIO : 45.00 (-1.53%)
ACLS : 100.25 (-1.94%)
WULF : 4.60 (+3.14%)
APLD : 5.95 (+7.01%)
HELE : 61.11 (+2.31%)
KYMR : 48.80 (-0.47%)
AGO : 81.38 (+0.30%)
Why Kymera Therapeutics Stock Is Soaring Today

Kymera's lead pipeline candidate received some good news.

KYMR : 48.80 (-0.47%)
Stock Index Futures Inch Higher Ahead of Powell’s Testimony

September S&P 500 E-Mini futures (ESU24) are up +0.16%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.27% this morning as market participants awaited Federal Reserve Chair Jerome Powell’s...

ESU24 : 5,702.50 (-0.27%)
NQU24 : 19,814.00 (-0.18%)
GLW : 44.23 (-0.45%)
INTC : 20.64 (-2.37%)
AMD : 154.23 (-1.60%)
MORF : 56.99 (+0.04%)
NKE : 86.04 (+6.25%)
JPM : 210.49 (unch)
WFC : 55.74 (-0.11%)
C : 61.87 (-1.82%)
DSY.FP : 36.010 (-1.48%)
BP-.LN : 409.550 (-1.89%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

ONCY : 0.9300 (-2.11%)
ONC.TO : 1.27 (-1.55%)
KYMR : 48.80 (-0.47%)
RHHBY : 39.4750 (+0.04%)
GILD : 83.28 (-0.74%)
AMGN : 336.85 (+0.27%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

ONCY : 0.9300 (-2.11%)
ONC.TO : 1.27 (-1.55%)
KYMR : 48.80 (-0.47%)
RHHBY : 39.4750 (+0.04%)
GILD : 83.28 (-0.74%)
AMGN : 336.85 (+0.27%)
Why Shares of Kymera Therapeutics Jumped on Tuesday

The company had a big bounce after hitting a 52-week low the day before.

SNY : 57.62 (-1.10%)
KYMR : 48.80 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

See More

Key Turning Points

3rd Resistance Point 53.75
2nd Resistance Point 52.22
1st Resistance Point 50.63
Last Price 48.80
1st Support Level 47.50
2nd Support Level 45.97
3rd Support Level 44.38

See More

52-Week High 50.69
Last Price 48.80
Fibonacci 61.8% 34.99
Fibonacci 50% 30.15
Fibonacci 38.2% 25.30
52-Week Low 9.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar